Weight-loss medication for psoriatic arthritis in people without diabetes
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study tests whether a medicine called a GLP-1 receptor agonist (a type of drug often used for weight and diabetes) can help people with psoriatic arthritis who are overweight but not diabetic. It may reduce joint symptoms and help with weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and of Chinese ethnicity.
- You have been diagnosed with psoriatic arthritis (a type of arthritis with skin psoriasis).
- Your body mass index (BMI) is 25 or higher.
- You do not have diabetes or have not taken GLP-1 medications in the past 6 months.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if semaglutide, a medicine used for diabetes and weight loss, can help people with both psoriasis and obesity. You may qualify if you have moderate to severe psoriasis, a high body weight, and are of Chinese descent.
This trial tests if semaglutide, a diabetes and weight-loss medication, can improve psoriasis symptoms and reduce inflammation. It may be an option for people with both psoriasis and overweight or obesity, with or without diabetes.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
Hear when a new Psoriasis Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.